PMID- 35330308 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220329 IS - 2309-608X (Electronic) IS - 2309-608X (Linking) VI - 8 IP - 3 DP - 2022 Mar 16 TI - Exclusion of Mucorales Co-Infection in a Patient with Aspergillus flavus Sinusitis by Fluorescence In Situ Hybridization (FISH). LID - 10.3390/jof8030306 [doi] LID - 306 AB - Invasive fungal infections are associated with increased mortality in hematological patients. Despite considerable advances in antifungal therapy, the evaluation of suspected treatment failure is a common clinical challenge requiring extensive diagnostic testing to rule out potential causes, such as mixed infections. We present a 64-year-old patient with secondary AML, diabetes mellitus, febrile neutropenia, and sinusitis. While cultures from nasal tissue grew Aspergillus flavus, a microscopic examination of the tissue was suggestive of concomitant mucormycosis. However, fluorescence in situ hybridization (FISH) using specific probes targeting Aspergillus and Mucorales species ruled out mixed infection. This was confirmed by specific qPCR assays amplifying the DNA of Aspergillus, but not of Mucorales. These results provided a rational basis for step-down targeted therapy, i.e., the patient received posaconazole after seven days of calculated dual therapy with liposomal amphotericin B and posaconazole. Despite clinical response to the antifungal therapy, he died due to the progression of the underlying disease within two weeks after diagnosis of fungal infection. Molecular diagnostics applied to tissue blocks may reveal useful information on the etiology of invasive fungal infections, including challenging situations, such as with mixed infections. A thorough understanding of fungal etiology facilitates targeted therapy that may improve therapeutic success while limiting side effects. FAU - Kessel, Johanna AU - Kessel J AD - Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany. FAU - Hogardt, Michael AU - Hogardt M AUID- ORCID: 0000-0002-0742-950X AD - Institute for Medical Microbiology and Infection Control, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany. FAU - Aspacher, Lukas AU - Aspacher L AD - Department of Internal Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany. FAU - Wichelhaus, Thomas A AU - Wichelhaus TA AD - Institute for Medical Microbiology and Infection Control, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany. FAU - Gerkrath, Jasmin AU - Gerkrath J AD - Robert Koch Institute Berlin, FG16, Seestrasse 10, 13353 Berlin, Germany. AD - Medizinische Klinik und Poliklinik II, Universitatsklinikum Wurzburg, 97080 Wuerzburg, Germany. FAU - Rosenow, Emely AU - Rosenow E AD - Robert Koch Institute Berlin, FG16, Seestrasse 10, 13353 Berlin, Germany. FAU - Springer, Jan AU - Springer J AD - Medizinische Klinik und Poliklinik II, Universitatsklinikum Wurzburg, 97080 Wuerzburg, Germany. FAU - Rickerts, Volker AU - Rickerts V AUID- ORCID: 0000-0002-6154-4920 AD - Robert Koch Institute Berlin, FG16, Seestrasse 10, 13353 Berlin, Germany. LA - eng PT - Case Reports DEP - 20220316 PL - Switzerland TA - J Fungi (Basel) JT - Journal of fungi (Basel, Switzerland) JID - 101671827 PMC - PMC8955397 OTO - NOTNLM OT - Aspergillus OT - fluorescence in situ hybridization (FISH) OT - fungal sinusitis OT - invasive fungal infection OT - mixed infection COIS- The authors declare no conflict of interest. EDAT- 2022/03/26 06:00 MHDA- 2022/03/26 06:01 PMCR- 2022/03/16 CRDT- 2022/03/25 01:12 PHST- 2022/02/22 00:00 [received] PHST- 2022/03/10 00:00 [revised] PHST- 2022/03/14 00:00 [accepted] PHST- 2022/03/25 01:12 [entrez] PHST- 2022/03/26 06:00 [pubmed] PHST- 2022/03/26 06:01 [medline] PHST- 2022/03/16 00:00 [pmc-release] AID - jof8030306 [pii] AID - jof-08-00306 [pii] AID - 10.3390/jof8030306 [doi] PST - epublish SO - J Fungi (Basel). 2022 Mar 16;8(3):306. doi: 10.3390/jof8030306.